Peschard P, Park M
Department of Biochemistry, Molecular Oncology Group, McGill University Health Center, McGill University, Montréal, Québec, Canada.
Oncogene. 2007 Feb 26;26(9):1276-85. doi: 10.1038/sj.onc.1210201.
The receptor for hepatocyte growth factor (HGF)/scatter factor (SF), Met, controls a program of invasive epithelial growth through the coordination of cell proliferation and survival, cell migration and epithelial morphogenesis. This process is important during embryogenesis and for organ regeneration in the adult. However, when deregulated the HGF/SF-Met signaling axis contributes to tumorigenesis and metastasis. Studies on the oncogenic activation of the Met receptor have shed light on the molecular mechanisms underlying the oncogenic activation of receptor tyrosine kinase (RTKs). More than a decade ago, work on the Met related oncogene, Tpr-Met, revealed the mechanism for activation of RTK-derived oncogenes generated following chromosomal translocation. More recently, studies on the mechanisms of downregulation of the Met RTK highlight a role for loss of downregulation in RTK oncogenic activation.
肝细胞生长因子(HGF)/分散因子(SF)的受体Met,通过协调细胞增殖与存活、细胞迁移和上皮形态发生,控制侵袭性上皮生长程序。这一过程在胚胎发育期间以及成体器官再生过程中都很重要。然而,当HGF/SF-Met信号轴失调时,会促进肿瘤发生和转移。对Met受体致癌激活的研究揭示了受体酪氨酸激酶(RTK)致癌激活背后的分子机制。十多年前,对与Met相关的致癌基因Tpr-Met的研究揭示了染色体易位后产生的RTK衍生致癌基因的激活机制。最近,对Met RTK下调机制的研究突出了下调缺失在RTK致癌激活中的作用。